Apr 16, 2024 | Biosimilars, Cost Savings, Drug costs, Humira, MedBen Rx, Pharmacy, Prescription, Rx Costs, Savings
Last year, MedBen Rx announced a new program that would enable clients to purchase Idacio, a biosimilar version of the anti-inflammatory therapy Humira – a drug that typically costs between $6,000 and $12,000 per month depending on the dose – for under $1,000 per...
Feb 5, 2024 | MedBen News, Online Services, Prescription, Telehealth, Weight loss, Zepbound
A major drug manufacturer is stepping up efforts to make its new weight-loss drug more accessible to potential users. Eli Lilly recently launched LillyDirect, a direct-to-consumer platform that connects obese patients to telehealth doctors who can prescribe the GLP-1...
Jan 22, 2024 | Access solutions, Benefits preservation, MedBen Rx, Pharmacy, Prescription, Specialty Drugs
A recent Segal Health Plan Cost Trend Survey projects 2024 cost trend for prescription drugs to approach 10%… but specialty drug trend alone may reach 15% this year, as increased use of expensive drugs continues to drive costs up. (We’ve actually seen...
Jan 3, 2024 | Artificial Intelligence, Prescription, Research
According to a Long Island University study, artificial intelligence tool ChatGPT’s answers to nearly 75% of drug-related questions were incomplete or wrong… and in some cases, even generated fake citations to support its answers. Researchers challenged the free...
Dec 22, 2023 | Acquisition Cost Index (ACI) pricing, Cost Plus Pricing, Cost Savings, Drug costs, MedBen Rx, Pharmacy, Prescription, Rx Costs, Savings, Spread Pricing
Spread pricing is the difference between what pharmacy benefit managers (PBMs) charge health plans for drugs and what the pharmacy actually pays for them. Often, this “spread” can be substantial, as PBMs profit greatly from their lack of transparency… so it’s not...
Nov 28, 2023 | Cancer, Cost Savings, Mental Health, Pharmacy, Prescription, Savings, Survey, Transparency
A recent survey of large employers by the Business Group on Health revealed considerations that self-funded plans expect to focus on in the coming year, including: Pharmacy costs. High-priced drugs and overall pharmacy costs are a source of concern for over 90% of...
